Brief: Peptonic Medical Q2 Operating Loss Widens To SEK 5.1 Mln
Aug 16 (Reuters) - Peptonic Medical AB PMED.TE :
* Q2 NET SALES OF PRODUCTS KSEK 1,011 (0)
* Q2 OPERATING LOSS KSEK -5,102 (-3,563)
* INTERIM REPORT PERIOD FROM JANUARY 2019 TO JUNE 2019
PEPTONIC
MEDICAL AB (PUBL) ORG NR 556776-3064 (WWW.AKTIETORGET.SE TICKER:
PMED)
Source text for Eikon: ID:nWkr21zH49
Further company coverage: PMED.TE
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Peptonic Medical AB
See all newsSweden's Peptonic Medical Q2 sales drop, gross margin narrows
Brief: Peptonic Medical Q2 Sales SEK 2.36 Million
Sweden's Peptonic Medical Q1 operating loss narrows on restructuring
Brief: Peptonic Medical Q1 Sales SEK 3.138 Million
Sweden's Peptonic Medical Q4 sales fall, margin improves on restructuring efforts